tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Ileus D045823 3 associated lipids
Rectal Diseases D012002 1 associated lipids
Angiolymphoid Hyperplasia with Eosinophilia D000796 1 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Mollison KW et al. Nephrotoxicity studies of the immunosuppressants tacrolimus (FK506) and ascomycin in rat models. 1998 Toxicology pmid:9570331
Salerno A et al. The effect of cyclosporin A, FK506 and rapamycin on the murine contact sensitivity reaction. 1998 Clin. Exp. Immunol. pmid:9566798
Pizzolato GP et al. Cerebral vasculitis during FK 506 treatment in a liver transplant patient. 1998 Neurology pmid:9566415
Kennedy AP et al. Polyomavirus middle T antigen as a probe for T cell antigen receptor-coupled signaling pathways. 1998 J. Biol. Chem. pmid:9565564
Yuzawa K and Fukao K Topical FK506 ointment for skin grafting. 1998 Transplantation pmid:9565111
Hayashi M et al. Allograft rejection after liver transplantation for autoimmune liver diseases. 1998 Liver Transpl Surg pmid:9563959
Jain A et al. Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferon. 1998 Liver Transpl Surg pmid:9563957
Fernández-Miranda C et al. Lipid abnormalities in stable liver transplant recipients--effects of cyclosporin, tacrolimus, and steroids. 1998 Transpl. Int. pmid:9561680
Cicalese L et al. Phenotypic and functional characteristics of intestinal intraepithelial lymphocytes during acute rejection of small intestinal allografts. 1998 Transpl. Int. pmid:9561676
Takaoka Y et al. Cyclosporin A and FK-506 inhibit development of superantigen-potentiated collagen-induced arthritis in mice. 1998 Gen. Pharmacol. pmid:9559334
Main ER et al. Context-dependent nature of destabilizing mutations on the stability of FKBP12. 1998 Biochemistry pmid:9558354
Taylor PJ et al. Therapeutic drug monitoring of tacrolimus (FK506) using tandem mass spectrometry. 1998 Ther Drug Monit pmid:9558142
Jubran RF and Dinndorf PA Successful therapy of refractory graft versus host disease with tacrolimus and Psoralen plus ultraviolet light. 1998 Ther Drug Monit pmid:9558141
Ku YM and Min DI An abbreviated area-under-the-curve monitoring for tacrolimus in patients with liver transplants. 1998 Ther Drug Monit pmid:9558138
Antonysamy MA et al. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients. 1998 J. Immunol. pmid:9558122
D'Incà R et al. Tacrolimus to treat pyoderma gangrenosum resistant to cyclosporine. 1998 Ann. Intern. Med. pmid:9556483
Terashima A et al. Single-channel activity of the Ca2+-dependent K+ channel is modulated by FK506 and rapamycin. 1998 Brain Res. pmid:9555045
Wiederrecht GJ et al. Mechanism of action of rapamycin: new insights into the regulation of G1-phase progression in eukaryotic cells. 1995 Prog Cell Cycle Res pmid:9552353
Hashimoto T et al. [Involvement of calcineurin A alpha and A beta in neuronal death in a gerbil model of cerebral ischemia]. 1998 Nippon Yakurigaku Zasshi pmid:9551469
Matsuda T and Baba A [Response of Na+/Ca2+ antiporter to ischemia and glial/neuronal death]. 1998 Nippon Yakurigaku Zasshi pmid:9551468
Epstein A et al. Cyclosporine, but not FK506, selectively induces renal and coronary artery smooth muscle contraction. 1998 Surgery pmid:9551073
ten Berge RJ and Schellekens PT [Immunology in clinical practice. VI. Current immunosuppressive drugs]. 1997 Ned Tijdschr Geneeskd pmid:9550813
Trull AK Therapeutic monitoring of tacrolimus. 1998 Ann. Clin. Biochem. pmid:9547889
Endrich MM and Gehring H The V3 loop of human immunodeficiency virus type-1 envelope protein is a high-affinity ligand for immunophilins present in human blood. 1998 Eur. J. Biochem. pmid:9546659
Matsuoka S et al. [Severe hepatic veno-occlusive disease (VOD) which was successfully treated with supportive therapy, but subsequently developed late-recurrence]. 1998 Rinsho Ketsueki pmid:9545827
Lopez-Ilasaca M et al. Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor. 1998 J. Biol. Chem. pmid:9545268
Bassing CH et al. FKBP12 is not required for the modulation of transforming growth factor beta receptor I signaling activity in embryonic fibroblasts and thymocytes. 1998 Cell Growth Differ. pmid:9543388
Hiroi J et al. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice. 1998 Jpn. J. Pharmacol. pmid:9541280
Anderson PO Tacrolimus and breastfeeding. 1998 Transplantation pmid:9539100
Schäffer MR et al. Tacrolimus impairs wound healing: a possible role of decreased nitric oxide synthesis. 1998 Transplantation pmid:9539093
Cichon G and Strauss M Transient immunosuppression with 15-deoxyspergualin prolongs reporter gene expression and reduces humoral immune response after adenoviral gene transfer. 1998 Gene Ther. pmid:9536268
Mattoo AK Peptidylprolyl cis-trans-isomerases from plant organelles. 1998 Meth. Enzymol. pmid:9534153
Wiederrecht G and Siekierka JJ Yeast immunophilins: purification and assay of yeast FKBP12. 1998 Meth. Enzymol. pmid:9534152
Ochiai M et al. Islet toxicity of FK506 measured in canine autografts. 1998 Transplant. Proc. pmid:9532224
Burke GW et al. Tacrolimus-related microangiopathy in kidney and simultaneous pancreas-kidney recipients: evidence of endothelin and cytokine involvement. 1998 Transplant. Proc. pmid:9532223
Elmer DS et al. Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts. 1998 Transplant. Proc. pmid:9532159
Corry RJ et al. Tacrolimus without antilymphocyte induction therapy prevents pancreas loss from rejection in 123 consecutive patients. 1998 Transplant. Proc. pmid:9532157
Gruessner RW et al. Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation. 1998 Transplant. Proc. pmid:9532156
Büsing M et al. Mycophenolate mofetil/tacrolimus/single-shot versus azathioprine/cyclosporine/ATG in pancreas-kidney transplantation: results of a prospective randomized single-center study. 1998 Transplant. Proc. pmid:9532155
Burke GW et al. Cholesterol control: long-term benefit of pancreas-kidney transplantation with FK 506 immunosuppression. 1998 Transplant. Proc. pmid:9532153
Peddi VR et al. Tacrolimus eliminates acute rejection as a major complication following simultaneous kidney and pancreas transplantation. 1998 Transplant. Proc. pmid:9532151
Bruce DS et al. Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation. 1998 Transplant. Proc. pmid:9532150
Kahl A et al. First results with a quadruple therapy regimen including tacrolimus and mycophenolate mofetil in patients after combined pancreas and kidney transplantation. 1998 Transplant. Proc. pmid:9532149
Corry RJ et al. Pancreas transplantation without antibody therapy. 1998 Transplant. Proc. pmid:9532050
First MR Clinical application of immunosuppressive agents in renal transplantation. 1998 Surg. Clin. North Am. pmid:9531936
Walensky LD et al. The 13-kD FK506 binding protein, FKBP13, interacts with a novel homologue of the erythrocyte membrane cytoskeletal protein 4.1. 1998 J. Cell Biol. pmid:9531554
Venkataraman C et al. Activation of lyn, blk, and btk but not syk in CD72-stimulated B lymphocytes. 1998 J. Immunol. pmid:9531290
Briffa N and Morris RE Immunosuppressive drugs after lung transplantation. 1998 BMJ pmid:9529396
Matsuda T et al. Immunosuppressants decrease neutrophil chemoattractant and attenuate ischemia/reperfusion injury of the liver in rats. 1998 J Trauma pmid:9529174
Mizunuma M et al. Role of calcineurin and Mpk1 in regulating the onset of mitosis in budding yeast. 1998 Nature pmid:9521328